Skip to main content

Appeals Court Affirms Enzo Defeat in Patent Dispute

NEW YORK, April 4 - The US Court of Appeals for the Federal Circuit affirmed a summary judgment that an Enzo Biochem patent directed at certain nucleic-acid probes is invalid because it lacks a written description of its claimed invention.

The three-judge panel affirmed the ruling by a two-to-one vote on Tuesday. Enzo, which stressed that the decision will not have any financial impact, said it was "disappointed" and will seek a rehearing before the full court of appeals. 
Enzo's suit named as defendants Becton-Dickinson, BioMerieux, Chugai Pharmaceutical, Chugai Pharma USA, and Gen-Probe.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.